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Prevention and Pirlimycin Therapy Strategies for a High
Somatic Cell Count Herd: A Case Study
A.S. Leaflet R1919
Leo Timms, Associate Professor of Animal Science
Summary and Implications
Objective of this field investigation was to: 1) examine
the etiology and mastitis infection dynamics in a 45 cow
herd and evaluate the efficacy of recommended and extended
therapy (S. aureus only) with pirlimycin hydrochloride
(Pirsue, Pharmacia/Upjohn Co. Kalamazoo, MI). for gram
positive intramammary infections (IMI) . Percentages of
cows (quarters) infected with Strep. agalactiae, Strep.
dysgalactiae, and Staph. aureus were 15(5); 54(23); 46(24);
respectively. Cow and quarter cure rates were: Strep.ag.-100,
100; Strep. dysgalactiae- 77, 86; Staph. aureus- 74, 85%.
High cure rates were seen for all organisms possibly due to
bacterial strains involved or the limited antibiotic therapy
seen in this herd over the previous 10 years. Observations
at the final herd visit showed significantly improved teat
end health and low new infection rate due to adoption of
immediate proposed strategies.  Herd SCC was down to
256,000 cells/ml within 1 month post treatment and
continued to be 250-350,000 cells/ml12 months later.
Targeting prevention and therapy strategies based on
causative organisms, and having a monitoring system in
place can result in sustained lower SCC and improved milk
quality and farm profitability.
The objectives of this field investigation were to: 1)
examine the etiology and mastitis infection dynamics in a
45 cow herd during the fall-winter whose normal herd bulk
tank SCC was 500,000 cells/ml but had jumped to 1
million for 3 months; 2) investigate herd management and
procedures and develop and prioritize necessary changes for
mastitis prevention; and 3) evaluate the efficacy of
recommended and extended therapy with pirlimycin
hydrochloride (Pirsue, Pharmacia/Upjohn Co. Kalamazoo,
MI). for gram positive intramammary infections (IMI) .
Materials and Methods
The herd (45 cows) involved in this case study was in
danger of market loss due to high SCC and was running
weekly individual cow SCC to avoid this. The initial
inquiry from the herd veterinarian only provided a single
Pro-Staph report showing 76% cows >400,000 SCC and
87% Pro-Staph positive (9% suspect). Following telephone
calls to the veterinarian, producer, and milk plant
fieldperson, individual quarter milk samples of all cows
were cultured and previous SCC data was obtained (32 cows
with chronic high SCC; 11 with occasional high SCC).
Within 3 weeks, an on-site herd visit at milking time was
conducted which included obtaining a second set of aseptic
quarter milk samples. Herd visit information showed a 18
kg/day milk average with cows in good body condition and
clean.  Cows were housed on pasture and milked in a 2 x 2
parlor.  Other housing areas included a small loafing area in
an old barn and a 50’ X 80’ bedded shed ( 1/3 full of
machinery). Premilking sanitation consisted of predipping
as well as washing with a lot of water, drying with paper
towels, no forestripping, and excessive time to unit
attachment.  There was some machine stripping and
individual quarters pulled off under vacuum, but vacuum
was usually shut off before milker unit removal. Teat
dipping with a .25 iodine dip provided fair to mediocre
coverage.  Units were dipped in hot iodine water between
cows.  Teat end observations showed many cracks and
lesions.  Milking machine analysis showed adequate pump
capacity, 53% regulator performance due to a dirty regulator
and small pipe sizing, two non-functional pulsators (dirty)
(Figure 1), inadequate claw and milkline size capacities, and
single pulsation. Strategies for preventing new IMI were
categorized as immediate (cleaned pulsators, cleaned
regulator, teat dip (better, more consistent coverage and a
1% iodine dip), milking procedures ( washing teats
eliminated, forestripping instituted, unit attach time
optimized, eliminated machine stripping and unit removal
under vacuum)), short (update equipment for proper sizing),
or long term (conversion of part of machinery shed to a free
stall barn) and were discussed and immediate changes were
implemented on that visit where possible. Based on
subsequent bacterial cultures, a herd therapy trial was
instituted. This herd had not treated intramammary (dry or
lactating) for at least 10  years. All gram + infected quarters
( excluding Staph. aureus)were treated IMM 2X 24 hr apart
with one 10 ml plastet 50 mg Pirlimycin HCl, with Staph.
aureus quarters treated 3 times with this series at 48 hrs
between treatment series. Individual cow SCC were run 21
days post treatment and the herd was visited 31 days post
treatment to obtain aseptic quarter milk samples and assess
prevention changes and results.
Results and Discussion
Herd culture results prior to the therapy trial are shown
in Table 1. The percentages of cows (quarters) uninfected or
infected with Strep. agalactiae, Strep. dysgalactiae, and
Staph. aureus were 17(46); 15(5); 54(23); 46(24);
respectively.  Only 46% of cows had Staph. aureus on
multiple cultures compared to 87% being Pro-Staph
positive. This supports that there was a high level of
exposure of Staph. aureus to many animals and quarters,
but lessened IMI probably due to the other established
Strep. IMI.  The high level of Strep. dysgalactiae correlates
well to the high degree of teat end lesions, while the
moderate level of Strep. agalactiae correlates to teat dip
coverage weaknesses.  Cultures 31 days post treatment (21
days post last treatment withdrawl times) (Table 2) showed
the following cow and quarter cure rates: Strep.ag.-100,
100; Strep. dysgalactiae- 77, 86; Staph. aureus- 74, 85%.
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High cure rates were seen for all organisms possibly due to
bacterial strains involved or the limited antibiotic therapy
seen in this herd over the previous 10 years. Observations
at this herd visit also showed significantly improved teat
end health ( pulsator and teat dip changes) and low new
infection rate due to adoption of immediate proposed
strategies.  Herd SCC was down to 256,000 cells/ml within
1 month post treatment. The herd was monitored over the
next 12 months and SCC continues to be 250-350,000
cells/ml. The herd is now dry treating, made milking
equipment changes to enhance flow capacity, and plans have
been developed to convert the bedded shed into a free stall
barn.
Table 1. Herd culture results prior to therapy based on 2 different samplings
                                              No. (%) cows                               No. (%) quarters  
    Uninfected                              7  (17%)                                     76  (46%)
    Strep. agalactiae                     6  (15%)                                       8  ( 5%)
    Strep. dysgalactiae               22  (54%)                                     38  (23%)
    Staph. aureus                       19  (46%)                                     39  (24%)
    Coag. neg. staph.                  1  ( 2%)                                        3  ( 2%)
Table 2. Cure rates for gram + IMI using recommended (*) or extended pirlimycin therapy (**)
                                          Strep.   agalactiae   *         Strep.   dysgalactiae   *           Staph.   aureus  **
     Cow cure rate                            100%                         77%                               74%
     Quarter cure rate                       100%                         86%                                85%
 *Recommended therapy = treated intramammary 2x with one 10 ml plastet 50 mg pirlimycin HCl 24 hrs apart;
**Extended therapy = 3 series of recommended therapies 48 hrs apart
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 Figure 1: Milking machine analysis graphs
